Orthofix Medical (OFIX) Accumulated Expenses (2010 - 2026)

Orthofix Medical has disclosed Accumulated Expenses across 17 years of filings, most recently posting $23.3 million for Q1 2026.

• Quarterly Accumulated Expenses changed N/A year-over-year to $23.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.3 million (changed N/A YoY) and the FY2025 annual result came in at $27.0 million, up 137.26% from the prior year.
• Accumulated Expenses eased to $23.3 million in Q1 2026, from $27.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $27.0 million in Q4 2025 and troughed at $7.0 million in Q4 2023.
• A 5-year average of $17.4 million and a median of $18.5 million in 2022 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses slumped 62.23% — and 2025, when it surged 137.26%.
• Tracing OFIX's Accumulated Expenses over 5 years: stood at $18.5 million in 2022, then slumped by 62.23% to $7.0 million in 2023, then jumped by 62.73% to $11.4 million in 2024, then jumped by 137.26% to $27.0 million in 2025, then retreated by 13.79% to $23.3 million in 2026.
• Business Quant data shows OFIX's Accumulated Expenses at $23.3 million in Q1 2026, $27.0 million in Q4 2025, and $11.4 million in Q4 2024.